PHYSIOLOGICAL AND PHARMACOKINETIC COMPLEXITIES IN BIOAVAILABILITY TESTING

被引:22
|
作者
RIEGELMAN, S [1 ]
机构
[1] UNIV CALIF, SCH PHARM, DEPT PHARM & PHARM CHEM, SAN FRANCISCO, CA 94122 USA
关键词
D O I
10.1159/000136329
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:118 / 141
页数:24
相关论文
共 50 条
  • [1] PHARMACOKINETIC BASIS OF BIOAVAILABILITY DETERMINATIONS
    COUET, W
    REIGNER, BG
    FOURTILLAN, JB
    [J]. THERAPIE, 1988, 43 (02): : 101 - 106
  • [2] PHARMACOKINETIC PROPERTIES AND BIOAVAILABILITY OF METHIMAZOLE
    JANSSON, R
    LINDSTROM, B
    DAHLBERG, PA
    [J]. CLINICAL PHARMACOKINETICS, 1985, 10 (05) : 443 - 450
  • [3] Unraveling the Physiological Complexities of Antibiotic Lethality
    Dwyer, Daniel J.
    Collins, James J.
    Walker, Graham C.
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 55, 2015, 55 : 313 - 332
  • [4] WHAT IS BIOAVAILABILITY - PHILOSOPHY OF BIOAVAILABILITY TESTING
    RITSCHEL, WA
    [J]. METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 1984, 6 (12): : 777 - 786
  • [5] The complexities of predictive genetic testing
    Evans, JP
    Skrzynia, C
    Burke, W
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2001, 322 (7293): : 1052 - 1056
  • [6] Complexities of Cardiac Genetic Testing
    Paljevic, Esma D.
    [J]. JNP-JOURNAL FOR NURSE PRACTITIONERS, 2019, 15 (01): : 139 - +
  • [7] PHYSIOLOGICAL PHARMACOKINETIC MODELING
    BALANT, LP
    GEXFABRY, M
    [J]. XENOBIOTICA, 1990, 20 (11) : 1241 - 1257
  • [8] Bioavailability and pharmacokinetic model for ritonavir in the rat
    Lledo-Garcia, R.
    Nacher, A.
    Prats-Garcia, L.
    Casabo, V. G.
    Merino-Sanjuan, M.
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2007, 96 (03) : 633 - 643
  • [9] Pharmacokinetic analysis, bioavailability and operating guidelines
    Marzo, A
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1997, 49 (12) : 1259 - 1260
  • [10] PHARMACOKINETIC STUDY OF FOSFOMYCIN AND ITS BIOAVAILABILITY
    CADORNIGA, R
    DIAZFIERROS, M
    OLAY, T
    [J]. CHEMOTHERAPY, 1977, 23 : 159 - 174